IL1B and COVID-19: Controversially, another study indicated that in severe COVID-19 cases, peripheral blood monocytes significantly increased expression of IL-6, TNF, IL-1β, and their receptors, as well as pro-inflammatory chemokines including CCL2, CCL3, and CCL4 [41].